ImportRefusal LogoImportRefusal

Central Pharmacy

⚠️ Moderate Risk

FEI: 1000288560 • London • UNITED KINGDOM

FEI

FEI Number

1000288560

📍

Location

London

🇬🇧
🏢

Address

225 West End Lane, , London, , United Kingdom

Moderate Risk

FDA Import Risk Assessment

43.0
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

7
Total Refusals
4
Unique Violations
11/7/2014
Latest Refusal
6/27/2012
Earliest Refusal

Score Breakdown

Violation Severity
75.0×40%
Refusal Volume
33.5×30%
Recency
0.0×20%
Frequency
29.6×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

167×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

757×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

Refusal History

DateProductViolationsDivision
11/7/2014
62ZPC07FILGRASTIM
16DIRECTIONS
472NO ENGLISH
75UNAPPROVED
Philadelphia District Office (PHI-DO)
11/7/2014
62TCP04OCTREOTIDE ACETATE (ANTI-SECRETORY)
16DIRECTIONS
75UNAPPROVED
Philadelphia District Office (PHI-DO)
11/7/2014
61PCP17INSULIN (INJ) (ANTI-DIABETIC)
16DIRECTIONS
75UNAPPROVED
Philadelphia District Office (PHI-DO)
11/7/2014
61HCA24ISONIAZID (ANTI-BACTERIAL)
16DIRECTIONS
75UNAPPROVED
Philadelphia District Office (PHI-DO)
11/7/2014
61HCA24ISONIAZID (ANTI-BACTERIAL)
16DIRECTIONS
75UNAPPROVED
Philadelphia District Office (PHI-DO)
11/7/2014
62ICK99ANTI-NEOPLASTIC N.E.C.
16DIRECTIONS
75UNAPPROVED
Philadelphia District Office (PHI-DO)
6/27/2012
62TCA06ESOMEPRAZOLE MAGNESIUM (ANTI-SECRETORY)
118NOT LISTED
16DIRECTIONS
75UNAPPROVED
Chicago District Office (CHI-DO)

Frequently Asked Questions

What is Central Pharmacy's FDA import refusal history?

Central Pharmacy (FEI: 1000288560) has 7 FDA import refusal record(s) in our database, spanning from 6/27/2012 to 11/7/2014.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Central Pharmacy's FEI number is 1000288560.

What types of violations has Central Pharmacy received?

Central Pharmacy has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Central Pharmacy come from?

All FDA import refusal data for Central Pharmacy is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.